Would be quite something if they'd managed to create fake results across 7 studies, the final one covering 12 hospital based trial sites, 989 patients. The whole thing coordinated by multiple 3rd party partners including CRO Accelagen, and Sonic Clinical Trials. I'm pretty sure it's proven to work!
They fell down with TGA because not enough evidence was provided to prove that it's reproducible across multiple batches. It most likely can achieve the required batch consistency (IMHO), but TGA has extremely high standards, especially for public health screening devices.
Ann: 2024 EGM Notice of Meeting, page-60
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RHY (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.85M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 10.0¢ | $5.166K | 51.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 164195 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.43pm 18/10/2024 (20 minute delay) ? |
| RHY (ASX) Chart |